Brandywine Managers’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-9,601
| Closed | -$206K | – | 41 |
|
|
2023
Q4 | $206K | Buy |
+9,601
| New | +$206K | 0.23% | 40 |
|
|
2023
Q3 | – | Sell |
-9,601
| Closed | -$283K | – | 42 |
|
|
2023
Q2 | $283K | Hold |
9,601
| – | – | 0.19% | 43 |
|
|
2023
Q1 | $221K | Hold |
9,601
| – | – | 0.16% | 46 |
|
|
2022
Q4 | $267K | Hold |
9,601
| – | – | 0.93% | 32 |
|
|
2022
Q3 | $295K | Hold |
9,601
| – | – | 0.97% | 31 |
|
|
2022
Q2 | $283K | Hold |
9,601
| – | – | 0.69% | 33 |
|
|
2022
Q1 | $309K | Hold |
9,601
| – | – | 0.53% | 37 |
|
|
2021
Q4 | $428K | Buy |
9,601
+1,050
| +12% | +$46.8K | 0.49% | 37 |
|
|
2021
Q3 | $431K | Hold |
8,551
| – | – | 0.45% | 38 |
|
|
2021
Q2 | $671K | Buy |
+8,551
| New | +$671K | 0.77% | 29 |
|